Therefore, this study aimed to evaluate the association of depression, anxiety, and cognitive impairment in patients with PD with cerebrospinal fluid (CSF) biomarkers, particularly α-synuclein, Aβ42, total Tau, and phosphorylated Tau. Here, MAPT is linked to depressive symptom measurement.